BNP/CALL/MERCK & CO./95/0.1/19.12.25 Share Price

Warrant

DE000PC1LLH5

Market Closed - Börse Stuttgart 08:12:51 05/07/2024 BST
3.37 EUR -0.88% Intraday chart for BNP/CALL/MERCK & CO./95/0.1/19.12.25
Current month-12.01%
1 month-7.42%
Date Price Change
05/07/24 3.37 -0.88%
04/07/24 3.4 -7.10%
03/07/24 3.66 +2.52%
02/07/24 3.57 +7.53%
01/07/24 3.32 -13.32%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 08:12 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1LLH
ISINDE000PC1LLH5
Date issued 11/12/2023
Strike 95 $
Maturity 19/12/2025 (530 Days)
Parity 10 : 1
Emission price 1.75
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.07
Lowest since issue 1.78
Delta0.84x
Omega 2.831
Premium4.71x
Gearing3.38x
Moneyness 1.331
Difference Strike -31.45 $
Difference Strike %-33.11%
Spread 0.02
Spread %0.58%
Theoretical value 3.450
Implied Volatility 29.14 %
Total Loss Probability 22.77 %
Intrinsic value 2.901
Present value 0.5488
Break even 132.40 €
Theta-0.01x
Vega0.03x
Rho0.09x

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus